8-KThe WireRoutine
Reg FD Disclosure
Filed Feb 14, 2023 · 3y ago · Accession 0001193125-23-036988
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Amylyx Pharmaceuticals, Inc.
- Ticker
- AMLX
- CIK
- 1658551
- Form type
- 8-K
- Filing date
- Feb 14, 2023
- Report date
- Feb 14, 2023
- Document
- d461886d8k.htm
- Size
- 147 KB